CD8A and breast carcinoma: Breast carcinoma tissue was analyzed by Cobas <i>PIK3CA</i> mutation test for the presence of <i>PIK3CA</i> mutation and immunohistochemistry was applied to assess PD-L1 expression and CD4, CD8, CD68, and CD163 infiltration within tumor.